Privia Health Group (NASDAQ:PRVA) Price Target Lowered to $34.00 at Canaccord Genuity Group

Privia Health Group (NASDAQ:PRVA) had its price target reduced by Canaccord Genuity Group from $35.00 to $34.00 in a research note released on Friday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.

Other analysts have also issued reports about the stock. Jefferies Financial Group restated a “buy” rating and set a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Truist Financial raised their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a research note on Monday, March 2nd. Piper Sandler restated an “overweight” rating and set a $36.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Citigroup reduced their price objective on shares of Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a research note on Tuesday, March 3rd. Finally, Barclays raised their price objective on shares of Privia Health Group from $23.00 to $25.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 25th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $31.23.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $23.10 on Friday. The firm has a market cap of $2.90 billion, a P/E ratio of 144.35, a P/E/G ratio of 1.50 and a beta of 0.96. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The firm has a 50-day simple moving average of $22.73 and a two-hundred day simple moving average of $23.34.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. The business had revenue of $603.85 million during the quarter, compared to analyst estimates of $560.99 million. Privia Health Group had a net margin of 0.97% and a return on equity of 2.81%. Privia Health Group’s revenue was up 25.8% compared to the same quarter last year. During the same period last year, the business earned $0.22 EPS. On average, equities research analysts predict that Privia Health Group will post 0.37 EPS for the current year.

Insider Transactions at Privia Health Group

In related news, Director Matthew Shawn Morris sold 1,017 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $24.96, for a total transaction of $25,384.32. Following the completion of the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,701,972.48. The trade was a 1.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Parth Mehrotra sold 26,509 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $22.11, for a total transaction of $586,113.99. Following the sale, the chief executive officer owned 555,443 shares of the company’s stock, valued at $12,280,844.73. This trade represents a 4.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 274,255 shares of company stock worth $6,299,092 over the last three months. 5.70% of the stock is currently owned by company insiders.

Institutional Trading of Privia Health Group

Large investors have recently added to or reduced their stakes in the business. Bayban bought a new stake in Privia Health Group during the fourth quarter valued at approximately $26,000. Hantz Financial Services Inc. grew its position in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after buying an additional 926 shares during the period. Global Retirement Partners LLC grew its position in Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after buying an additional 1,351 shares during the period. Canada Pension Plan Investment Board grew its position in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares during the period. Finally, Kestra Advisory Services LLC bought a new stake in Privia Health Group during the fourth quarter valued at approximately $93,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group News Summary

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia Health reported first-quarter results that beat revenue expectations, with sales of $603.85 million versus the $560.99 million estimate, and EPS of $0.19 versus $0.08 expected. The company also said revenue rose 25.8% year over year, and it reiterated full-year 2026 guidance. Article Title
• Positive Sentiment: The company’s updated 2026 outlook calls for revenue of $2.4 billion to $2.5 billion, which is in line with or slightly above market expectations and supports the case for continued growth. Article Title
• Neutral Sentiment: Investors are also parsing the Q1 2026 earnings call transcript and related earnings coverage for management commentary on margins, utilization trends, and the path to hitting full-year targets. Article Title
• Negative Sentiment: Two insider-selling reports may be weighing on sentiment: the CFO sold about $179,690 of stock and a director sold about $427,229 of stock, which can signal caution even when fundamentals are improving. Article Title Article Title

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.